IGKV1D-22 and myeloid sarcoma: Immunomodulatory effects of tobacco smoke-derived nicotine are implicated as a risk factor for MS by a study showing that polymorphisms in loci encoding for α7 and α9 nAChRs modify the association between smoking and MS [85].